Inventor · disambiguated record
Juswinder Singh
Also filed as: SINGH JUSWINDER
69 granted patents·21 pending applications·1,149 citations·filing 1996–2021
99Inventor score
Files withCELGENE CAR LLC29CELGENE AVILOMICS RES INC28SINGH JUSWINDER8NIU DEQIANG5AVILA THERAPEUTICS INC4
Top patents by PatentIndex Score
90 records- 0199US8609679B22,4-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 17, 2013·84 cites·4 claims
- 0298US8710222B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Apr 29, 2014·52 cites·3 claims
- 0398US8450335B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted May 28, 2013·130 cites·22 claims
- 0498US8338439B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted Dec 25, 2012·175 cites·2 claims
- 0597US9987276B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jun 5, 2018·23 cites·26 claims
- 0697US8975249B2Heterocyclic compounds and uses thereofLEE KWANGHO·Filed 2011·Granted Mar 10, 2015·57 cites·25 claims
- 0796US10577380B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2019·Granted Mar 3, 2020·10 cites·4 claims
- 0896US9561228B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Feb 7, 2017·37 cites·17 claims
- 0996US9375431B22,4-disubstituted pyrimidine compounds useful as kinase inhibtorsCELGENE AVILOMICS RES INC·Filed 2015·Granted Jun 28, 2016·21 cites·29 claims
- 1096US9212181B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 15, 2015·34 cites·42 claims
- 1195US10010548B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jul 3, 2018·15 cites·4 claims
- 1295US9409921B22,4-disubstituted pyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2014·Granted Aug 9, 2016·25 cites·2 claims
- 1395US9296737B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Mar 29, 2016·27 cites·23 claims
- 1494US10253040B1MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted Apr 9, 2019·12 cites·15 claims
- 1594US9867824B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jan 16, 2018·11 cites·14 claims
- 1694US9458175B2MK2 inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Oct 4, 2016·16 cites·32 claims
- 1794US9145387B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Sep 29, 2015·21 cites·28 claims
- 1894US7989465B24,6-disubstituted pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2009·Granted Aug 2, 2011·26 cites·4 claims
- 1993US9980964B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted May 29, 2018·11 cites·28 claims
- 2093US9790235B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 17, 2017·12 cites·18 claims
- 2193US9765038B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Sep 19, 2017·11 cites·20 claims
- 2293US9238629B2Heteroaryl compounds and uses thereofLEE KWANGHO·Filed 2011·Granted Jan 19, 2016·18 cites·17 claims
- 2393US8980935B2HCV protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Mar 17, 2015·7 cites·26 claims
- 2493US8741837B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Jun 3, 2014·10 cites·23 claims
- 2593US8309685B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2009·Granted Nov 13, 2012·20 cites·36 claims
- 2692US10081606B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Sep 25, 2018·8 cites·8 claims
- 2792US9504686B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Nov 29, 2016·10 cites·40 claims
- 2892US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 2992US8524760B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Sep 3, 2013·9 cites·13 claims
- 3092US8293705B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted Oct 23, 2012·12 cites·15 claims
- 3192US8188137B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted May 29, 2012·13 cites·29 claims
- 3291US9796700B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 24, 2017·7 cites·17 claims
- 3390US11351168B12,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2020·Granted Jun 7, 2022·2 cites·3 claims
- 3490US10828300B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Nov 10, 2020·3 cites·27 claims
- 3590US10596172B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Mar 24, 2020·5 cites·3 claims
- 3690US8329901B24,6-disubstitued pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted Dec 11, 2012·11 cites·5 claims
- 3790US7982036B24,6-disubstitued pyrimidines useful as kinase inhibitorsAVILA THERAPEUTICS INC·Filed 2008·Granted Jul 19, 2011·13 cites·12 claims
- 3889US11096942B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Aug 24, 2021·2 cites·14 claims
- 3989US10138256B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Nov 27, 2018·11 cites·12 claims
- 4089US8748606B24,6-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Jun 10, 2014·8 cites·4 claims
- 4189US8242271B2Heterocyclic compounds and uses thereofSINGH JUSWINDER·Filed 2008·Granted Aug 14, 2012·9 cites·31 claims
- 4288US10434101B2Heterocyclic compounds and uses thereofCELGENE CAR LLC·Filed 2018·Granted Oct 8, 2019·4 cites·17 claims
- 4388US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 4488US8778877B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2008·Granted Jul 15, 2014·10 cites·26 claims
- 4588US8445498B24,6-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2011·Granted May 21, 2013·8 cites·17 claims
- 4687US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 4785US9422333B2HCV protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Aug 23, 2016·2 cites·19 claims
- 4885US9040541B24,6-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2013·Granted May 26, 2015·5 cites·24 claims
- 4985US8586600B2Heterocyclic compounds and uses thereofSINGH JUSWINDER·Filed 2012·Granted Nov 19, 2013·6 cites·12 claims
- 5084US11584757B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2020·Granted Feb 21, 2023·1 cites·20 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Juswinder Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →